The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis
Aim: To evaluate the clinic-pathological features and prognostic value regarding PSMD14 in cancers.Materials & methods: Literature was gathered from public databases until 22 June 2023 to analyze data on survival rates and clinicopathological characteristics associated with PSMD14. TCGA and GEO...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2024.2409054 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850094511384952832 |
|---|---|
| author | Shu-Yi Dong Shuxin Ding Zhen Meng Bo Zou |
| author_facet | Shu-Yi Dong Shuxin Ding Zhen Meng Bo Zou |
| author_sort | Shu-Yi Dong |
| collection | DOAJ |
| description | Aim: To evaluate the clinic-pathological features and prognostic value regarding PSMD14 in cancers.Materials & methods: Literature was gathered from public databases until 22 June 2023 to analyze data on survival rates and clinicopathological characteristics associated with PSMD14. TCGA and GEO data were also utilized for validation.Results: Eight reports on seven types of tumors showed that high PSMD14 expression was linked to poorer overall survival and disease-free survival. PSMD14 expression also correlated with larger tumor size, differentiation and metastasis, as well as the effectiveness of various chemotherapy drugs.Conclusion: PSMD14 could serve as a potential biomarker of poor prognosis in cancers, including lung cancer, head and neck squamous cell carcinoma, ovarian cancer, breast cancer and hepatocellular carcinoma. |
| format | Article |
| id | doaj-art-01f2a0293b1a4b6286f9ba059ef1e088 |
| institution | DOAJ |
| issn | 2056-5623 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Future Science OA |
| spelling | doaj-art-01f2a0293b1a4b6286f9ba059ef1e0882025-08-20T02:41:39ZengTaylor & Francis GroupFuture Science OA2056-56232024-12-0110110.1080/20565623.2024.2409054The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysisShu-Yi Dong0Shuxin Ding1Zhen Meng2Bo Zou3Department of Oral & Maxillofacial Surgery, Liaocheng People's Hospital, Medical College of Liaocheng University, Liaocheng, Shandong, P. R. ChinaDepartment of Oral & Maxillofacial Surgery, Liaocheng People's Hospital, Medical College of Liaocheng University, Liaocheng, Shandong, P. R. ChinaDepartment of Oral & Maxillofacial Surgery, Liaocheng People's Hospital, Medical College of Liaocheng University, Liaocheng, Shandong, P. R. ChinaDepartment of Oral & Maxillofacial Surgery, Liaocheng People's Hospital, Medical College of Liaocheng University, Liaocheng, Shandong, P. R. ChinaAim: To evaluate the clinic-pathological features and prognostic value regarding PSMD14 in cancers.Materials & methods: Literature was gathered from public databases until 22 June 2023 to analyze data on survival rates and clinicopathological characteristics associated with PSMD14. TCGA and GEO data were also utilized for validation.Results: Eight reports on seven types of tumors showed that high PSMD14 expression was linked to poorer overall survival and disease-free survival. PSMD14 expression also correlated with larger tumor size, differentiation and metastasis, as well as the effectiveness of various chemotherapy drugs.Conclusion: PSMD14 could serve as a potential biomarker of poor prognosis in cancers, including lung cancer, head and neck squamous cell carcinoma, ovarian cancer, breast cancer and hepatocellular carcinoma.https://www.tandfonline.com/doi/10.1080/20565623.2024.2409054bioinformatical analysiscancermeta-analysisPSMD14 |
| spellingShingle | Shu-Yi Dong Shuxin Ding Zhen Meng Bo Zou The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis Future Science OA bioinformatical analysis cancer meta-analysis PSMD14 |
| title | The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis |
| title_full | The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis |
| title_fullStr | The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis |
| title_full_unstemmed | The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis |
| title_short | The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis |
| title_sort | clinicopathological and prognostic significance of psmd14 in cancers based on bioinformatics and meta analysis |
| topic | bioinformatical analysis cancer meta-analysis PSMD14 |
| url | https://www.tandfonline.com/doi/10.1080/20565623.2024.2409054 |
| work_keys_str_mv | AT shuyidong theclinicopathologicalandprognosticsignificanceofpsmd14incancersbasedonbioinformaticsandmetaanalysis AT shuxinding theclinicopathologicalandprognosticsignificanceofpsmd14incancersbasedonbioinformaticsandmetaanalysis AT zhenmeng theclinicopathologicalandprognosticsignificanceofpsmd14incancersbasedonbioinformaticsandmetaanalysis AT bozou theclinicopathologicalandprognosticsignificanceofpsmd14incancersbasedonbioinformaticsandmetaanalysis AT shuyidong clinicopathologicalandprognosticsignificanceofpsmd14incancersbasedonbioinformaticsandmetaanalysis AT shuxinding clinicopathologicalandprognosticsignificanceofpsmd14incancersbasedonbioinformaticsandmetaanalysis AT zhenmeng clinicopathologicalandprognosticsignificanceofpsmd14incancersbasedonbioinformaticsandmetaanalysis AT bozou clinicopathologicalandprognosticsignificanceofpsmd14incancersbasedonbioinformaticsandmetaanalysis |